Files

Download

Abstract or Poster Image (128 KB)

Description

Cancer is the leading cause of death worldwide. The current treatment options available for lung cancer are limited and have drawbacks such as poor bioavailability, numerous side effects, poor efficacy and drug resistance. 3D model serve as a novel approach for drug screening purposes and the evaluation of compounds in the platform can help identify potent compounds for further in vivo xenograft studies.

Publication Date

9-6-2012

Disciplines

Analytical, Diagnostic and Therapeutic Techniques and Equipment | Medicine and Health Sciences | Other Analytical, Diagnostic and Therapeutic Techniques and Equipment | Pharmaceutics and Drug Design

Comments

Student Researchers: Janine M. Naim; Rati Lama

Faculty Advisor: Bin Su, Ph.D.

Anti-cancer Drug Screening of Dual Tubulin and Hsp27 Inhibitors with 2D and 3D Lung Cancer Cell Assays

Share

COinS